Structure of HIV gag p24 223–231 (HLA-B*07:02)
Logo for Infectious disease
Infectious disease

HIV gag p24 223–231 (HLA-B*07:02) GPGHKARVL

€210.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart
Product number: EP11261_5

Description

GPGHKARVL is a linear peptidic epitope (epitope ID21635) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide HIV gag p24 223–231 (HLA-B*07:02) GPGHKARVL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

TechData

Sequence: GPGHKARVL
Gene: gag
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 5 mg
Counterion: TFA
Protein: Gag polyprotein
Species: HIV
Allele: HLA-B*07:02
Application: Flow Cytometry
Indication: Infectious disease
Purity: 95% HPLC-MS
Skip product gallery

More HIV gag proteins

HIV Gag 150-158 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed Gag-derived peptide of RTLNAWVKV sequence covering 150-158 and A*02:01 molecule.

From €105.00*
HIV gag 197-205 (H-2 Kd)
Antigen Peptide Gag Pol polyprotein H-2 Kd (AMQMLKETI) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*
HIV Gag 433-440 (HLA-A*02:01)
Therapeutic vaccination of chronically infected HIV-1 subjects was evaluated as a means of halting disease progression. A subdominant peptide vaccine containing 15 CTL epitopes and 3 helper T-cell peptides along with an adjuvant was delivered to 18 infected subjects. Using IFN-? EliSpot, 9 new T-cell responses were detected in 6/14 subjects whose viral loads (VL) remained stable. 7/10 CTL and other pre-existing responses, however, were not significantly detected. Gag433, FLGKIWPS, is a CTL epitope sequence used as a vaccine component.

From €105.00*
HIV Gag 50-59 (HLA-A*02:01)
SLFNTVATLY is a linear peptidic epitope (epitope ID127083) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assay and MHC ligand assays

From €105.00*
HIV Gag 77-85 (HLA-A*02:01)
SLFNTVATL is a linear peptidic epitope (epitope ID131070) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
HIV gag 79-86 (HLA-A*29:02)
LYNTVATLY is a linear peptidic epitope (epitope ID126652) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1, tested in MHC ligand assays

From €105.00*
HIV gag p17 28-36 (HLA-A*24)
The peptide HIV gag p17 28-36 (HLA-A*24) with the amino acid sequence KYKLKHIVW is a linear peptidic epitope (epitope ID 34482) studied as part of Gag polyprotein (UniProt:P04591) from Lentivirus humimdef1.HIV gag p17 28-36 (HLA-A*24) has been studied for immune reactivity in publications and has been tested in T cell assays.

From €105.00*
HIV gag p24 128-135 (HLA-B*08:01)
The peptide HIV gag p24 128-135 (HLA-B*08:01) with the amino acid sequence EIYKRWII is a linear peptidic epitope (epitope ID 12616) studied as part of Gag polyprotein (UniProt:P04591) from Lentivirus humimdef1 and Gag-Pol polyprotein (UniProt:P04585) from Lentivirus humimdef1.HIV gag p24 128-135 (HLA-B*08:01) has been studied for immune reactivity in publications and has been tested in T cell assays.

From €105.00*
HIV p24-Gag 263-272 (HLA-B*27:05)
KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1 and Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Single peptide HIV p24-Gag (HLA-B*27:05) 263-272 (KRWIILGLNK) for stimulation of human HIV p24-Gag(263-272)-specific CD8+ T-cells.

From €105.00*
HIV p24-Gag 30-40 (HLA-B*57:01)
HIV p24-Gag peptide KAFSPEVIPMF (HLA-B*5701) is a single peptide for stimulation of T cells. The peptide from human immunodeficiency virus 1 (HIV-1) p24 group-specific antigen (Gag) is synthesized as it is presented by the MHC class I HLA-B*5701 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.

From €105.00*
Tip
HIV-1 B Gag Peptide Pool
Pool of 123 peptides derived from a peptide scan (15mers with 11 aa overlap) through Gag polyprotein (Uni-Prot ID P04591) of Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1). One unit allows the stimulation of 2,5 x 108 cells.

€316.90*
HIV-1 gag p17 20-28 (HLA-A*03:01)
RLRPGGKKK is a linear peptidic epitope (epitope ID54741) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity and tested in T cell assays

From €105.00*
HIV-1 gag p24 19-27 (HLA-A*02:01)
TLNAWVKVV is a linear peptidic epitope (epitope ID64961) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
HIV-1 gag p24 261-269 (HLA-B*08:01)
GEIYKRWII is a linear peptidic epitope (epitope ID19313) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assay and MHC ligand assays

From €105.00*
HIV-1 Gag p24 263-272 (HLA-B*27:05)
KRWIIMGLNK is a linear peptidic epitope (epitope ID184136) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*